The science related to e-cigarettes (or e-cigs) remains hazy at best, primarily because e-cigs are relatively new to the marketplace. Nonetheless, scientists are diligently working to collect data on the use of e-cigs and their potential health effects. A simple PubMed search for published articles with the term "e-cigarette" in the title reveals about 50 publications in 2015 alone; this is just scratching the surface. Innovative Science Solutions (ISS) has been closely tracking the latest scientific developments related to e-cigs (see here for a post on tracking the science), as well as the US Food & Drug Administration's (FDA's) activities on this front—including its recent three-part workshop on e-cigs. In this post, we provide an update on some of the latest science that has emerged with regard to the safety and efficacy of e-cigs as smoking-cessation tools.Read More
Bridging the Gap Between Science and the Law
This article was authored by Bill Wilt of Assured Research. In this post, Bill provides an advanced summary of research that was performed for an upcoming White Paper on asbestos science and liability. The White Paper will be published as a joint offering by Innovative Science Solutions, Assured Research, and Kirk Hartley. You can find brief biographical sketches on both Bill and Kirk at the end of the blog post.
ISS and A2L have just published the new and revised second edition of our ebook, The Litigator’s Guide to Combating Junk Science, Second Edition. Don't let junk science corrupt the facts in your case. Download your copy of our ebook today, and strike back against misinformation, unsubstantiated claims, and misleading data.
This post was authored by Kenneth Lipartito, Ph.D. and Patricia A. Watson, Ph.D. of the Business History Group. Kenneth Lipartito is Professor of History at Florida International University in Miami and Principal in the Business History Group. An award-winning author of books on the history of business and technology, he has served as an expert witness and consultant in cases involving lead, asbestos and other consumer products. Patricia A. Watson is a historian of medicine and Principal of the Business History Group. She has worked with a wide range of business clients, including Merck, PriceWaterhouseCoopers, WSJ Online, American Express and L’Oreal, and provided expert historical research in cases involving lead, asbestos and PCBs.Read More
Our genes are made up of DNA—long strands of nucleotides (the G, C, A, and T sequences) that serve as our genetic code. The term genome refers to all the genes that make up an organism. Our genome is stored inside our cells. Cells make up tissues, tissues make up organs, and organs make up organisms.Read More
This piece was co-authored by Catherine Vick, an epidemiologist at Venebio, who offers services to an array of clients, from lawyers litigating complex scientific cases to research organizations requiring advanced data analytics and data management. Ms. Vick has over 15 years of experience in public health, program evaluation, and health outcomes research in academic, federal, and biopharmaceutical arenas.Read More
Dietary supplement products have come under greater scrutiny in the past few years. These products can face a number of challenges, including the permissibility of ingredients, and safety and efficacy. An effective tool to respond to these challenges is a proactively prepared substantiation package (i.e. a package that addresses the safety, efficacy, and ingredient permissibility). And when it comes to claims substantiation packages, a small upfront investment can go a long way in defending a dietary supplement company’s reputation and revenue stream.Read More
An Interview with Gary Marchant, JD, Ph.D.
Genomic science is finding its way into multiple facets of our legal system and it is establishing itself as a major force changing the face of causation evidence in the courtroom. We recently caught up with Gary Marchant to talk about his view on the role of genomics in the legal arena and his view on how this science is likely to change the practice of law in complex cases involving personal injury, product liability, toxic tort, and intellectual property cases.
In a previous post, we talked about the importance of tracking the science related to electronic cigarettes (e-cigarettes or e-cigs). In this post, we turn to the regulatory framework and what issues we believe are likely to come under FDA scrutiny in the near future.Read More